By Counterforce Health Team in Daybue (trofinetide) —

Getting Daybue (Trofinetide) Covered by Cigna in New York: Prior Authorization, Appeals, and Cost Assistance

Answer Box: Fastest Path to Daybue Coverage with Cigna in New York

Daybue (trofinetide) requires prior authorization from Cigna and must be dispensed through a designated specialty pharmacy. To get coverage:

  1. Submit PA request with confirmed Rett syndrome diagnosis, patient age ≥2 years, and specialist attestation
  2. Use Cigna's "Neurology – Daybue" policy as your checklist for required documentation
  3. If denied, file internal appeal within 180 days, then external appeal with NY Department of Financial Services within 4 months

First step today: Contact your prescriber to initiate the prior authorization using Cigna's coverage policy IP0578 and ensure your prescription routes to an approved specialty pharmacy.

Table of Contents

Coverage Requirements at a Glance

Requirement What It Means Where to Find It Source
Prior Authorization Required for all Daybue prescriptions Cigna provider portal or fax submission Cigna Policy IP0578
Specialty Pharmacy Must use Cigna-designated specialty pharmacy Express Scripts/Accredo network Cigna Policy IP0578
Age Requirement Patient must be ≥2 years old FDA labeling criteria FDA Daybue Label
Diagnosis Confirmation Documented Rett syndrome diagnosis Clinical notes, genetic testing Cigna Policy IP0578
Specialist Attestation Neurology or genetics provider certification Prescriber documentation Cigna Policy IP0578
Internal Appeal Deadline 180 days from denial NY insurance law NY DFS External Appeals
External Appeal Deadline 4 months from final internal denial NY insurance law NY DFS External Appeals

Step-by-Step: Fastest Path to Approval

1. Verify Specialty Pharmacy Network

Who: Patient or caregiver
Document needed: Insurance card and member ID
How to submit: Call Cigna member services
Timeline: Same day
Source: Cigna member portal

2. Gather Required Documentation

Who: Prescribing physician and patient
Documents needed:

  • Confirmed Rett syndrome diagnosis with ICD-10 codes
  • Patient age verification (≥2 years)
  • Clinical notes documenting current symptoms and functional status
  • Genetic testing results if available (MECP2 mutation)
  • Weight-based dosing calculation

Timeline: 1-3 business days
Source: Cigna Policy IP0578

3. Submit Prior Authorization Request

Who: Prescribing physician or clinic staff
How to submit: Cigna provider portal or fax
Expected timeline: 72 hours for standard review, 24 hours for expedited
Source: Cigna formulary exception process

4. Route Prescription to Specialty Pharmacy

Who: Prescriber
Document needed: Approved PA and prescription
Timeline: 24-48 hours after PA approval
Source: Cigna Policy IP0578

5. Coordinate Patient Enrollment

Who: Specialty pharmacy and patient
Documents needed: Insurance information, shipping address, administration plan
Timeline: 3-5 business days

Understanding Daybue Costs and Assistance Options

Daybue's reported list price is approximately $21.10 per mL, with monthly costs varying based on weight-based dosing. For a typical patient, this can translate to around $9,495 per 450-mL bottle.

Manufacturer Support Programs

Daybue Copay Card (Commercial Insurance)
Eligible patients with commercial insurance may pay as little as $0 per month through Acadia Connect. Contact 1-844-737-2223 for enrollment. This program is not available for government-funded insurance (Medicare, Medicaid).

Patient Assistance Program
Uninsured or underinsured patients may qualify for zero-cost medication through Acadia's Patient Assistance Program based on income and insurance status.

Foundation Support

Assistance Fund: Rett Syndrome
Provides copay assistance specifically for FDA-approved Rett syndrome medications. U.S. citizens or permanent residents with commercial insurance or Medicare/Medicaid may qualify based on financial need.

International Rett Syndrome Foundation (IRSF)
Offers Family Empowerment Grants for medical costs, therapy expenses, and adaptive equipment. Applications are evaluated based on need and available funding.

From our advocates: We've seen families successfully combine manufacturer copay cards with foundation grants to cover deductibles and coinsurance. Start with the manufacturer program first, then apply for foundation support for remaining costs. Document all expenses—even denied coverage can strengthen foundation applications.

Common Denial Reasons and Solutions

Denial Reason How to Overturn Required Documentation
Diagnosis not substantiated Provide genetic testing and specialist evaluation MECP2 results, neurology/genetics consultation notes
Age outside FDA label Verify patient age ≥2 years Birth certificate, medical records
Missing specialist attestation Obtain neurology or genetics provider certification Specialist evaluation and treatment plan
Quantity limit exceeded Justify weight-based dosing calculation Current weight, BSA calculation, dosing rationale
Site-of-care restrictions Document medical necessity for enteral administration G-tube documentation, administration plan

Most effective appeal strategy: Address each denial reason point-by-point using Cigna's own policy criteria. Include peer-reviewed literature supporting Daybue's efficacy in Rett syndrome and emphasize it's the first and only FDA-approved therapy for this condition.

Appeals Process in New York

New York provides robust patient protections for insurance appeals, with binding external review through the Department of Financial Services.

Internal Appeal (Required First Step)

  • Deadline: 180 days from denial
  • Cigna timeline: 30 days for standard appeals, 72 hours for expedited
  • How to file: Written request via Cigna member portal or mail
  • Required: Copy of denial letter, supporting medical documentation

External Appeal (After Internal Denial)

  • Deadline: 4 months from final internal denial
  • NY DFS timeline: 30 days standard, 72 hours expedited (24 hours for urgent drug denials)
  • Cost: Maximum $25 (waived for Medicaid or financial hardship)
  • How to file: NY DFS External Appeals portal
  • Decision: Binding on both patient and insurer
Tip: For urgent needs, request expedited review at both internal and external levels. Have your prescriber certify that delay would pose serious health risks.

Support Resources:

Clinician Corner: Medical Necessity Documentation

Essential Elements for PA Success

Patient History & Diagnosis

  • Confirmed Rett syndrome diagnosis with supporting clinical criteria
  • Genetic testing results (MECP2 mutation if available)
  • Current functional status and symptom severity
  • Age verification (≥2 years per FDA labeling)

Clinical Rationale

  • Explanation of Daybue as first FDA-approved Rett syndrome therapy
  • Treatment goals and expected outcomes
  • Weight-based dosing calculation and administration plan
  • Monitoring plan for common adverse effects (diarrhea, vomiting)

Supporting Literature

Documentation Checklist:

  • ICD-10 diagnosis codes
  • Current weight and BSA
  • Specialist consultation notes
  • Genetic testing results
  • Functional assessment scores
  • Treatment history and response

Patient Scripts and Templates

Calling Cigna Member Services

"Hi, I'm calling about prior authorization status for Daybue, spelled D-A-Y-B-U-E, for my [relationship] who has Rett syndrome. The generic name is trofinetide. My member ID is [number]. Can you tell me the status of our PA request submitted on [date] and what additional documentation might be needed?"

Requesting Expedited Review

"We need to request an expedited prior authorization review for Daybue because [patient name] has Rett syndrome and any delay in starting this FDA-approved therapy could worsen their neurological symptoms and quality of life. This is the only approved treatment for their rare condition."

Specialty Pharmacy Coordination

"I'm calling to confirm that you're an approved Cigna specialty pharmacy for Daybue (trofinetide). Our PA was approved on [date] with reference number [if available]. When can we expect the medication to ship, and what's your process for coordinating refills?"

FAQ: Daybue Coverage with Cigna

Q: How long does Cigna prior authorization take for Daybue in New York?
A: Standard PA requests are reviewed within 72 hours. Expedited requests (when medically urgent) are reviewed within 24 hours. Source: Cigna formulary exception process

Q: What if Daybue is not on Cigna's formulary?
A: You can request a formulary exception by demonstrating medical necessity. Your prescriber must document why formulary alternatives are not appropriate for Rett syndrome (none exist as FDA-approved therapies).

Q: Can I get Daybue from my regular pharmacy?
A: No, Cigna requires Daybue to be dispensed through designated specialty pharmacies only. Contact Cigna to identify approved specialty pharmacy options.

Q: What happens if my internal appeal is denied?
A: You have 4 months to file an external appeal with the NY Department of Financial Services. Their decision is binding on Cigna and costs no more than $25.

Q: Does step therapy apply to Daybue?
A: Typically no, since Daybue is the first and only FDA-approved therapy for Rett syndrome. However, some plans may require documentation that supportive therapies have been tried.

Q: How do I prove medical necessity for Daybue?
A: Provide confirmed Rett syndrome diagnosis, specialist evaluation, current functional status, and documentation that this is the only FDA-approved therapy for the condition.

Q: Can I appeal based on cost if I can't afford my copay?
A: While you can't appeal the copay amount itself, you can apply for manufacturer assistance programs and foundation grants. Document financial hardship when applying for patient assistance.

Q: What if I move to New York from another state while on Daybue?
A: Contact Cigna to ensure continuity of coverage. New York's transition of care provisions may require temporary coverage while you complete any new PA requirements.

Getting Daybue covered by Cigna in New York requires careful attention to documentation and deadlines, but the state's strong patient protection laws provide multiple avenues for appeal if initially denied. The key is thorough preparation of medical necessity documentation and understanding your appeal rights.

For families navigating this process, Counterforce Health helps patients, clinicians, and specialty pharmacies turn insurance denials into targeted, evidence-backed appeals. Their platform analyzes denial letters and plan policies to create point-by-point rebuttals aligned with payer requirements, potentially saving weeks in the appeals process.

Remember that Daybue represents a breakthrough as the first FDA-approved therapy specifically for Rett syndrome. With proper documentation and persistence through New York's appeals process, coverage can be obtained even after initial denials.

Sources & Further Reading

This article is for informational purposes only and does not constitute medical or legal advice. Always consult with your healthcare provider and insurance plan for specific coverage decisions. For assistance with insurance appeals and coverage issues, contact Counterforce Health or Community Health Advocates at 888-614-5400.

Powered by Counterforce Health—AI that turns drug denials into evidence-based appeals patients and clinicians can submit today.